Neutropenia: occurrence and management in women with breast cancer receiving chemotherapy

Authors

  • Talita Garcia do Nascimento Faculdade Barretos
  • Marceila de Andrade Prefeitura Municipal de Ribeirão Preto
  • Rosemeire Aparecida de Oliveira Universidade de São Paulo; Escola de Enfermagem de Ribeirão Preto
  • Ana Maria de Almeida Universidade de São Paulo; Escola de Enfermagem de Ribeirão Preto
  • Thais de Oliveira Gozzo Universidade de São Paulo; Escola de Enfermagem de Ribeirão Preto

DOI:

https://doi.org/10.1590/0104-1169.3305.2416

Abstract

OBJECTIVES: to identify the prevalence, and describe the management of, neutropenia throughout the chemotherapy treatment among women with breast cancer. METHODS: observational study, cycles of chemotherapy. 116 neutropenic events were recorded, and 63.3% of the patients presented neutropenia at some point of their treatment, 46.5% of these presenting grade II. The management used was temporary suspension between the cycles and the mean number of delays was 6 days. The study was prospective and longitudinal, where the evaluation of the hematological toxicities was undertaken at each cycle of chemotherapy, whether neoadjuvant or adjuvant. RESULTS: 79 women were included, who received 572 cycles. However, the reasons for the suspensions were the lack of a space in the chemotherapy center, followed by neutropenia. CONCLUSION: neutropenia is one of the most common and serious adverse events observed during the chemotherapy. Nursing must invest in research regarding this adverse event and in management strategies for organizing the public health system, so as to offer quality care.

Downloads

Download data is not yet available.

Downloads

Published

2014-04-01

Issue

Vol. 22 No. 2 (2014)

Section

Original Articles

License

RLAE’s authorship concept is based on the substantial contribution by each of the individuals listed as authors, mainly in terms of conceiving and planning the research project, collecting or analyzing and interpreting data, writing and critical review. Indication of authors’ names under the article title is limited to six. If more, authors are listed on the online submission form under Acknowledgements. The possibility of including more than six authors will only be examined on multicenter studies, considering the explanations presented by the authors.
Including names of authors whose contribution does not fit into the above criteria cannot be justified. Those names can be included in the Acknowledgements section.
 Authors are fully responsible for the concepts disseminated in their manuscripts, which do not necessarily reflect the editors’ and editorial board’s opinion.

 

How to Cite

Neutropenia: occurrence and management in women with breast cancer receiving chemotherapy . (2014). Revista Latino-Americana De Enfermagem, 22(2), 301-308. https://doi.org/10.1590/0104-1169.3305.2416